Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension

Cardiol Young. 2019 Nov;29(11):1323-1327. doi: 10.1017/S104795111900235X. Epub 2019 Sep 26.


Pulmonary hypertension is a complex and progressive condition that is either idiopathic or heritable, or associated with one or multiple health conditions, with or without congenital or acquired cardiovascular disease. Recent developments have tremendously increased the armamentarium of diagnostic and therapeutic approaches in children and young adults with pulmonary hypertension that is still associated with a high morbidity and mortality. These modalities include non-invasive imaging, pharmacotherapy, interventional and surgical procedures, and supportive measures. The optimal, tailored diagnostic and therapeutic strategies for pulmonary hypertension in the young are rapidly evolving but still face enormous challenges: Healthcare providers need to take the patient's age, development, disease state, and family concerns into account when initiating advanced diagnostics and treatment. Therefore, there is a need for guidance on core and advanced medical training in paediatric pulmonary hypertension. The Association for European Paediatric and Congenital Cardiology working group "pulmonary hypertension, heart failure and transplantation" has produced this document as an expert consensus statement; however, all recommendations must be considered and applied in the context of the local and national infrastructure and legal regulations.

Keywords: Association for European Paediatric and Congenital Cardiology; Pulmonary hypertension; children; heart disease; young adults.

Publication types

  • Review

MeSH terms

  • Cardiology / education*
  • Child
  • Consensus*
  • Education, Medical, Graduate / standards*
  • Europe
  • Guidelines as Topic*
  • Humans
  • Hypertension, Pulmonary / congenital*
  • Societies, Medical*